NCT05271695

Brief Summary

Nutrition is essential in the treatment and management of Type 2 Diabetes. The importance of adding foods with anti-inflammatory effects to daily diet plans in ensuring glycemic control, preventing the progression of diabetes, and reducing the risk of complications in the future is revealed by new studies added to the literature every day. This study aimed to determine the effects of the dietary inflammatory index (DII) on inflammation markers and metabolic parameters by determining the food consumption status of adults with type 2 diabetes who have good glycemic control.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2020

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

February 17, 2022

Completed
20 days until next milestone

First Posted

Study publicly available on registry

March 9, 2022

Completed
Last Updated

March 9, 2022

Status Verified

February 1, 2022

Enrollment Period

5 months

First QC Date

February 17, 2022

Last Update Submit

February 27, 2022

Conditions

Keywords

Dietary inflammatory index (DII)InflammationType 2 diabetesinflammatory markersbiochemical parameters

Outcome Measures

Primary Outcomes (4)

  • Current serum TNF-α value

    Serum TNF-α values in the current nutritional status of patients with and without type 2 diabetes will be examined.

    At the end of the 10-hour fasting of the patients, a single time

  • Current serum IL-6 value

    Serum IL-6values in the current nutritional status of patients with and without type 2 diabetes will be examined.

    At the end of the 10-hour fasting of the patients, a single time

  • Current serum IL-1β value

    Serum IL-1β values in the current nutritional status of patients with and without type 2 diabetes will be examined.

    At the end of the 10-hour fasting of the patients, a single time

  • Current Dietary Inflammatory Index score

    The Dietary Inflammatory Index score of the current nutritional status of patients with and without type 2 diabetes will be evaluated. In this study, 31 foods and nutrients were determined from food consumption records. The amounts of nutrients were calculated using the nutrient analysis program. Dietary inflammatory index (DII) score was calculated from these foods. In order to calculate the diet inflammatory index score, the z-score must first be calculated. To calculate the Z-score, the standard global consumption amount is subtracted from the average consumption amount of the individual. The result obtained is divided by the standard deviation value. The z score found with this result is converted to the percentile score. The percentile value is multiplied by the full inflammatory effect score. DII is obtained as a result of summing the scores calculated for all nutrients and nutrients. Found DII is an indicator of the inflammatory load of the individual's daily diet.

    At the end of the 10-hour fasting of the patients, a single time

Secondary Outcomes (13)

  • Current serum glucose value

    At the end of the 10-hour fasting of the patients, a single time

  • Current serum HbA1c value

    At the end of the 10-hour fasting of the patients, a single time

  • Current waist circumference measurement

    At the end of the 10-hour fasting of the patients, a single time

  • Current weight

    At the end of the 10-hour fasting of the patients, a single time

  • Current BMI

    At the end of the 10-hour fasting of the patients, a single time

  • +8 more secondary outcomes

Study Arms (2)

The patients with type 2 diabetes

* Patients with a diagnosis of Type 2 Diabetes Mellitus and HbA1c ≤ 7% * Patients using or not using oral antidiabetic drugs * Patients who inject insulin once or twice a day or repeated insulin injections

The healthy controls

* Patients diagnosed with Type I Diabetes Mellitus, * Patients with HbA1c \> 7% * Those with gestational diabetes, * Breastfeeding diabetics, * Patients with renal dysfunction, * Patients with acute and chronic infection status

Eligibility Criteria

Age30 Years - 74 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

This study was selected among adult type 2 diabetes patients under control at Istanbul University Istanbul Medical Faculty Diabetes Polyclinic between November 2019 and April 2020. The 120 patients included studying were between the ages of 30-74 and were sent to the diet polyclinic by their physicians. As the control group, 30 healthy people from the same age group were included. The data were collected by the researcher by face-to-face interview.

You may qualify if:

  • Patients with a diagnosis of Type 2 Diabetes Mellitus and HbA1c ≤ 7%
  • Patients using or not using oral antidiabetic drugs
  • Patients who inject insulin once or twice a day or repeated insulin injections

You may not qualify if:

  • Patients diagnosed with Type I Diabetes Mellitus,
  • Patients with HbA1c \> 7%
  • Those with gestational diabetes,
  • Breastfeeding diabetics,
  • Patients with renal dysfunction,
  • Patients with acute and chronic infection status

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul University, Faculty of Medicine, Department of Endocrinology and Metabolism

Istanbul, Capa, 34093, Turkey (Türkiye)

Location

Related Publications (18)

  • Steckhan N, Hohmann CD, Kessler C, Dobos G, Michalsen A, Cramer H. Effects of different dietary approaches on inflammatory markers in patients with metabolic syndrome: A systematic review and meta-analysis. Nutrition. 2016 Mar;32(3):338-48. doi: 10.1016/j.nut.2015.09.010. Epub 2015 Oct 28.

    PMID: 26706026BACKGROUND
  • Cavicchia PP, Steck SE, Hurley TG, Hussey JR, Ma Y, Ockene IS, Hebert JR. A new dietary inflammatory index predicts interval changes in serum high-sensitivity C-reactive protein. J Nutr. 2009 Dec;139(12):2365-72. doi: 10.3945/jn.109.114025. Epub 2009 Oct 28.

    PMID: 19864399BACKGROUND
  • Shivappa N, Steck SE, Hurley TG, Hussey JR, Hebert JR. Designing and developing a literature-derived, population-based dietary inflammatory index. Public Health Nutr. 2014 Aug;17(8):1689-96. doi: 10.1017/S1368980013002115. Epub 2013 Aug 14.

    PMID: 23941862BACKGROUND
  • Wirth MD, Shivappa N, Steck SE, Hurley TG, Hebert JR. The dietary inflammatory index is associated with colorectal cancer in the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Br J Nutr. 2015 Jun 14;113(11):1819-27. doi: 10.1017/S000711451500104X. Epub 2015 Apr 14.

    PMID: 25871645BACKGROUND
  • McGeoghegan L, Muirhead CR, Almoosawi S. Association between an anti-inflammatory and anti-oxidant dietary pattern and diabetes in British adults: results from the national diet and nutrition survey rolling programme years 1-4. Int J Food Sci Nutr. 2015 Aug;67(5):553-61. doi: 10.1080/09637486.2016.1179268. Epub 2016 May 4.

    PMID: 27144647BACKGROUND
  • King DE, Xiang J. The Dietary Inflammatory Index Is Associated With Diabetes Severity. J Am Board Fam Med. 2019 Nov-Dec;32(6):801-806. doi: 10.3122/jabfm.2019.06.190092.

    PMID: 31704748BACKGROUND
  • Schwingshackl L, Chaimani A, Hoffmann G, Schwedhelm C, Boeing H. A network meta-analysis on the comparative efficacy of different dietary approaches on glycaemic control in patients with type 2 diabetes mellitus. Eur J Epidemiol. 2018 Feb;33(2):157-170. doi: 10.1007/s10654-017-0352-x. Epub 2018 Jan 4.

    PMID: 29302846BACKGROUND
  • Benson G, Hayes J. An Update on the Mediterranean, Vegetarian, and DASH Eating Patterns in People With Type 2 Diabetes. Diabetes Spectr. 2020 May;33(2):125-132. doi: 10.2337/ds19-0073.

    PMID: 32425449BACKGROUND
  • Meng Y, Bai H, Wang S, Li Z, Wang Q, Chen L. Efficacy of low carbohydrate diet for type 2 diabetes mellitus management: A systematic review and meta-analysis of randomized controlled trials. Diabetes Res Clin Pract. 2017 Sep;131:124-131. doi: 10.1016/j.diabres.2017.07.006. Epub 2017 Jul 8.

    PMID: 28750216BACKGROUND
  • Kirkpatrick CF, Bolick JP, Kris-Etherton PM, Sikand G, Aspry KE, Soffer DE, Willard KE, Maki KC. Review of current evidence and clinical recommendations on the effects of low-carbohydrate and very-low-carbohydrate (including ketogenic) diets for the management of body weight and other cardiometabolic risk factors: A scientific statement from the National Lipid Association Nutrition and Lifestyle Task Force. J Clin Lipidol. 2019 Sep-Oct;13(5):689-711.e1. doi: 10.1016/j.jacl.2019.08.003. Epub 2019 Sep 13.

    PMID: 31611148BACKGROUND
  • Ley SH, Hamdy O, Mohan V, Hu FB. Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet. 2014 Jun 7;383(9933):1999-2007. doi: 10.1016/S0140-6736(14)60613-9.

    PMID: 24910231BACKGROUND
  • Robertson L, Waugh N, Robertson A. Protein restriction for diabetic renal disease. Cochrane Database Syst Rev. 2007 Oct 17;2007(4):CD002181. doi: 10.1002/14651858.CD002181.pub2.

    PMID: 17943769BACKGROUND
  • Estruch R, Ros E, Salas-Salvado J, Covas MI, Corella D, Aros F, Gomez-Gracia E, Ruiz-Gutierrez V, Fiol M, Lapetra J, Lamuela-Raventos RM, Serra-Majem L, Pinto X, Basora J, Munoz MA, Sorli JV, Martinez JA, Fito M, Gea A, Hernan MA, Martinez-Gonzalez MA; PREDIMED Study Investigators. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. N Engl J Med. 2018 Jun 21;378(25):e34. doi: 10.1056/NEJMoa1800389. Epub 2018 Jun 13.

    PMID: 29897866BACKGROUND
  • Wang DD, Li Y, Chiuve SE, Stampfer MJ, Manson JE, Rimm EB, Willett WC, Hu FB. Association of Specific Dietary Fats With Total and Cause-Specific Mortality. JAMA Intern Med. 2016 Aug 1;176(8):1134-45. doi: 10.1001/jamainternmed.2016.2417.

    PMID: 27379574BACKGROUND
  • Wheeler ML, Dunbar SA, Jaacks LM, Karmally W, Mayer-Davis EJ, Wylie-Rosett J, Yancy WS Jr. Macronutrients, food groups, and eating patterns in the management of diabetes: a systematic review of the literature, 2010. Diabetes Care. 2012 Feb;35(2):434-45. doi: 10.2337/dc11-2216. No abstract available.

    PMID: 22275443BACKGROUND
  • Brown TJ, Brainard J, Song F, Wang X, Abdelhamid A, Hooper L; PUFAH Group. Omega-3, omega-6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled trials. BMJ. 2019 Aug 21;366:l4697. doi: 10.1136/bmj.l4697.

    PMID: 31434641BACKGROUND
  • Arulselvan P, Fard MT, Tan WS, Gothai S, Fakurazi S, Norhaizan ME, Kumar SS. Role of Antioxidants and Natural Products in Inflammation. Oxid Med Cell Longev. 2016;2016:5276130. doi: 10.1155/2016/5276130. Epub 2016 Oct 10.

    PMID: 27803762BACKGROUND
  • Kizil M, Tengilimoglu-Metin MM, Gumus D, Sevim S, Turkoglu I, Mandiroglu F. Dietary inflammatory index is associated with serum C-reactive protein and protein energy wasting in hemodialysis patients: A cross-sectional study. Nutr Res Pract. 2016 Aug;10(4):404-10. doi: 10.4162/nrp.2016.10.4.404. Epub 2016 Mar 29.

    PMID: 27478547BACKGROUND

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Inflammation

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD; Academician; Principle Investigator

Study Record Dates

First Submitted

February 17, 2022

First Posted

March 9, 2022

Study Start

November 1, 2019

Primary Completion

April 1, 2020

Study Completion

April 1, 2020

Last Updated

March 9, 2022

Record last verified: 2022-02

Locations